YuemingChangMDPh.D

Journal Articles

• The Importance of Preclinical Trial Timing – a Potential Reason for the Disconnect between mouse Studies and Human Clinical Trials in ALS  
  Qiongman Kong, 1 Sarah Carothers, 1 Yueming Chang, 1 and Chien‐Liang Glenn Lin, CNS Neurosci Ther., 6/19/2012
• RNA oxidation: A contributing factor or an epiphenomenon in the process of neurodegeneration  
  Qiongman Kong, Xiu Shan,Yueming Chang, Hirofumi Tashiro &Chien-Liang Glenn Lin, Free Radical Research, 7/7/2009
• The presence of rRNA sequences in polyadenylated RNA and its potential functions  
  Qiongman Kong Michael P. Stockinger Yueming Chang Hirofumi Tashiro Chien‐liang Glenn Lin Dr., Biotechnology Journal, 8/13/2008
• Messenger RNA Oxidation Occurs Early in Disease Pathogenesis and Promotes Motor Neuron Degeneration in ALS  
  Yueming Chang,Qiongman Kong,Xiu Shan,Guilian Tian,Hristelina Ilieva,Don W. Cleveland,Jeffrey D. Rothstein,David R. Borchelt,Philip C. Wong,Chien-liang Glenn Lin, Plos One, 8/6/2008
• A novel noncoding RNA rescues mutant SOD1‐mediated cell death  
  Yueming Chang Michael P. Stockinger Hirofumi Tashiro Chien‐liang Glenn Lin, FASEB journal, 10/23/2007
• Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression  
  Xiu Shan Yueming Chang Chien‐liang Glenn Lin, FASEB Journal, 5/11/2007
• Translational Control of Glial Glutamate Transporter EAAT2 Expression  
  GuilianTian, LichingLai, HongGuo, YuanLin, Matthew E.R.Butchbach, YuemingChang, Chien-liang GlennLin, Journal of Biological chemistry, 1/19/2007
• Join now to see all

Abstracts/Posters

• BCR Signalosome-Oriented Phosphotyrosine Profiling of CLL
  Yueming Chang, MD PhD , Jeffrey S Wasser, MD , Adam Boruchov, MD , Bruce J Mayer, PhD , Kazuya Machida, MDPhD, Blood, Orlando, 12/4/2015